Revision as of 09:01, 13 February 2018

Meeting Minutes

Others phone numbers : https://phastinternational.webex.com/cmp3100/webcomponents/widget/globalcallin/globalcallin.do?siteurl=phastinternational&serviceType=MC&ED=329202667&tollFree=0

Access code: 956 796 372

PHARM FHIR profiles and roadmap
- Current: MMA , UBP Profile
- Upcoming: Supply of medication and devices, Adverse event reporting.

FHIR Roadmap and strategy - profiles and publication
- ExampleScenario, IG Publisher
- Join the workgroup on the documentation.

E-medication is based on clinical workflows.
E-prescriptions is focused on reimbursement of the prescription costs.
A prescription actually consists of 2 components:
- a therapeutical element
- a logistical element.
Medication list is based on the therapeutical elements.
Discussion of exceptional cases:
- standard prescription process
- home visit scenarios
- blanc prescriptions where patient and medication is filled in.
Prescription ID is set immedicately on creation.
There must be always a medication line on a prescription.
Should we change the constraints on prescriptions? There are different options:
- relax the constraints on e-prescriptions to deal with the exceptions.
- call it a seperate document ( ordonance) do not regard it as a prescription.
Considers the legal impact on the possible options.
Recommendation to regard this as a seperate document.
We wait for the official Austrian requirements before we make a change.

There is a complaint about the use of namespaces. The name of the namespace was requested by Oliver Egger, but not done correctly.
The need of the namespace was because the HL7 Cmet had to be adapted.
The reason is that software generation tools need to create their own alias.
Remove any constraint on the alias of the pharm.xml namespace in th prescription profile. The name can be chosen as wanted.
This would give issues on the transformation of stylesheets.

@@ Line 69: / Line 69: @@
 * Recommendation to regard this as a seperate document.
 * We wait for the official Austrian requirements before we make a change.
+<br>
+* There is a complaint about the use of namespaces. The name of the namespace was requested by Oliver Egger, but not done correctly.
+* The need of the namespace was because the HL7 Cmet had to be adapted.
+* The reason is that software generation tools need to create their own alias.
+* Remove any constraint on the alias of the pharm.xml namespace in th prescription profile. The name can be chosen as wanted.
+* This would give issues on the transformation of stylesheets.
 == 13:30 - 14:30 Adverse Event Reporting ==